mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.4 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |